Monographie - Caffeine citrate - Stabilis 4.0

最新更新 :
19/11/2024

呼吸刺激薬

Caffeine citrate

注射薬

経口液

溶媒内の安定性

混合時の安定性

安定性に影響する因子

互換性

投与経路

引用文献

PDF

化学構造

商品名

商品名

商品名、賦形剤は国、製薬会社ごとに異なることがあります

Cafcit	アメリカ
Cafeina 25% Bioquim	アルゼンチン
Cafeina citrato	スペイン
Cafeina Fada	アルゼンチン
Cafeine citrate Biomed	ニュージーランド
Cafeine Sterop	ベルギー
Cafeinnova	コロンビア
Caffeinospire	エジプト
Cafirate	インド
Citrate de caféine Cooper	フランス
Peyona oral y para perfusion	スペイン
Peyona oral/parenteral	トルコ, ドイツ, ルーマニア

引用文献

注射薬

引用文献 : Caffeine citrate

	形式	出版物
43	雑誌	Fraser BD, Berod T, Whitney HAK. Stability of caffeine citrate injection in polypropylene syringes at room temperature. Am J Health-Syst Pharm 1997 ; 54: 1106-1108.
318	雑誌	Donnelly RF, Tirona RG. Stability of citrated caffeine injectable solution in glass vials. Am J Hosp Pharm 1994 ; 51: 512-514.
691	雑誌	Nahata MC, Zingarelli JR, Durell DE. Stability of caffeine citrate injection in intravenous admixtures and parenteral nutrition solutions. J Clin Pharm Ther 1989 ; 14: 53-55.
1802	雑誌	Bell MS, Nolt DH. Visual compatibility of doxapram hydrochloride with drugs commonly administered via a Y-site in the intensive care nursery. Am J Health-Syst Pharm 2003 ; 60: 193-194.
2087	雑誌	Ferreira E, Forest JM, Hildgen P. Compatibility of dimenhydrinate injectable by Y administration. Pharmactuel 2004 ; 37: 17-20.
3379	雑誌	Fox L.M, Wilder A.G, Foushee J.A. Physical compatibility of various drugs with neonatal total parenteral nutrient solution during simulated Y-site administration. Am J Health-Syst Pharm 2013 ;70:520-524.
3644	実験	Calcium gluconate® - Summary of Product Characteristics Hameln Pharmaceuticals 2010
3976	雑誌	Du Repaire T, Vigne P, Guedon A, Gauthier-Villano L, Bertault Peres P, Pourroy B. Visual compatibility of blinatumomab with selected co-administrated drugs during simulated Y-site administration. Am J Health-Syst Pharm 2017 ; 74,16 : 1217-1218
4319	雑誌	Lessard J-J, Caron E, Schérer H, Forest J-M, Leclair G. Compatibility of Y-site Injection of Meropenem Trihydrate With 101 Other Injectable Drugs. Hosp Pharm 2020 ; 55, 5: 332-337.
4389	雑誌	Côté K, Correal F, Metras M.E, Friciu M, Forest J.M, Leclair G. Compatibilité physique des médicaments administrés en Y aux soins intensifs, en particulier la dexmédétomidine, le lévosimendan et la kétamine. Pharmactuel 2019 ;52,4:206-213
4419	雑誌	Holt R.J, Siegert S.W.K, Krishna A. Physical Compatibility of Ibuprofen Lysine Injection with Selected Drugs During Simulated Y-site Injection. J Pediatr Pharmacol Ther 2008 ; 13, 3: 155-161.
4543	雑誌	Senarathna G, Strunk T, Petrovski M, Batty K. Physical compatibility of pentoxifylline and intravenous medications. Archives of Disease in Childhood 2018 ;104:292–295.
4603	雑誌	Vallée M, Barthélémy I, Friciu M, Pelletier E, Forest J.M, Benoit F, Leclair G. Compatibility of Lactated Ringer’s Injection With 94 Selected Intravenous Drugs During Simulated Y-site Administration. Hosp Pharm 2021 ; 56, 4: 228-234.
4742	雑誌	Macoviciuc M, Nguyen C, Forest J-M, Leclair G. Compatibilité physique de l’acétaminophène injectable avec 102 autres médicaments lors d’une administration en Y. Pharmactuel 2022 ; 55, 4: 247-255.
4837	雑誌	De Silva, D.T.N Petrovski M, Strunk T, Mukadam N, Page‑Sharp N, Moore B.R, Batty K.T. Physicochemical compatibility of caffeine citrate and caffeine base injections with parenteral medications used in neonatal intensive care settings. Eur J Clin Pharmacol 2024 ; 80:1079–1087.

Mentions Légales